Topic Archives: ProMIS Neurosciences (PMN.TO ARFXF)

I got several reader questions this week about a new recommendation from Dave Lashmet at Stansberry — it looks like this was issued as a recommendation for regular Stansberry Investment Advisory subscribers, not one of Lashmet’s more expensive biotech-focused newsletters, and it’s very light on clues… but let’s see if we can give you anything […]

“This Wednesday, September 5 Tuesday, May 28, a group of scientists will take the stage at a prestigious medical conference… “And announce to the world the potential end of disease as we know it.” That’s the attention-getting part of Ray Blanco’s latest teaser ad for his FDA Trader newsletter that Gumshoe readers have been asking […]

Ray Blanco makes (part of) his living looking for biotech moonshots, like most biotech-focused newsletter writers — and like his predecessor at Agora’s biotech and emerging tech-focused newsletter Breakthrough Technology Alert, he has often touted companies that are trying to end the scourge of Alzheimer’s Disease. Why? Well, two main reasons: First, and by far […]

Comments

  • Avatar

    Promis Neurosciences (ARFXF) is tackling ALS, Alzheimer’s and Parkinson’s disease. I don’t know why these guys ar...

  • Avatar

    ARFXF on the OTC in the US. The company has been around since 2006. Does not seem to have ever gotten much traction in...

  • Avatar

    Thank you for your amazing article . My father died from AD and finding a cure means so much to me . There is a small ...

  • Avatar

    It is likely PROMIS NEUROSCIENCES INC ticker symbol ARFXF...

  • Travis Johnson, Stock Gumshoe

    Excitement about Alzheimer's drugs sometimes spurs big movements in Phase 1 and 2, though so far almost all of them have...

  • Avatar

    I'm trying to assess the opportunity for an investment in Promis Neurosciences. They are a pre-clinical stage biotech co...

  • DrKSSMDPhD

    Gummies investing in this company (ProMIS) need to step back and ask themselves "My God what have I done?" (Talking Head...

  • Avatar

    $PMN.TO Hi TVR, I am not sure if MB is still a proponent of this stock. There seemed to be some disputes between him ...

  • Avatar

    PMN.to NP – As someone who lost their father to alzheimer’s disease, I did a fair bit of research into this company ...

  • Avatar

    PMN.to NP - As someone who lost their father to alzheimer's disease, I did a fair bit of research into this company in t...

  • Avatar

    $ARFXF PROMis Neurosciences This co was recently pumped by Agora and covered by Travis here: https://www.stockgum...

  • Avatar

    $PMN.to NP $ARFXF Morning Doc. A company that is on my radar is presenting at Noble Con tomorrow at 9:30AM. They ar...

  • Avatar

    I thought this was interesting. The Co posted this TORONTO and CAMBRIDGE, MA, Jan. 22, 2018 /PRNewswire/ - At the reques...

  • Avatar

    ProMIS just published a White Paper. Must read. https://promisneurosciences.com/2016site/wp-content/uploads/2018/01/v.fi...

  • Avatar

    This morning’s press release: Humanized PMN310 Shows Significantly Greater Binding to The Toxic Oligomer Fraction o...

  • Avatar

    Thank you for the detailed reply. I really appreciate your input and effort....

  • Avatar

    I'm not under an NDA with Promis and I don't have any information that other investors do not have....

  • SoGiAm

    #AlzheimersDisease #AD - Dr. KSS MD PhD Re: $PMN.v $ARFXF My intent in commenting on ProMIS is not to make it look r...

  • DrKSSMDPhD

    My intent in commenting on ProMIS is not to make it look risible (I don't question its sincerity in its approach and its...

  • Avatar

    Give Dr Cashman time! He has already shown that Big Pharma are the cruel ones. They have been selling useless meds to "t...

  • Avatar

    I figured out who it was yesterday Travis, and when I saw it was pre-stage my immediate enthusiasm waned. However, if a...

  • Avatar

    Disclaimer: I'm the largest shareholder in this company. I have no clue what the February 14th headline is. The way t...

  • Avatar

    It's s shame that Blanco can't be even remotely honest. Yes, it will be fantastic the day that Alzheimer's is beaten, b...

  • DrKSSMDPhD

    We've pretty much broken the back of this one in the biotech threads. "Danger Will Robinson!"...

  • arch1

    Chris You bring some good info. I have Np in the companies discussed and the following is only opinion from short look....

  • Avatar

    Dr. KSS, Let me begin by first thanking you most sincerely for this extremely thought-provoking response. I am in yo...

  • Avatar

    $PMN.TO (no position) For GJ: Absolutely outstanding post, shipmate! You have obviously rolled up your sleeves an...

  • DrKSSMDPhD

    Hello GJ, and welcome to the group. I am glad you are here, and appreciate that you are both reading and posting. Commen...

  • Avatar

    GJ: I have been here a rather long time, but its your 'newbie' blood...your passion, that teaches us something everyday....

  • Avatar

    Good afternoon to all, I will apologize in advance for the length of this post, and especially so if I have unintenti...

  • SoGiAm

    Tuesday, August 2, 2016 Dear Subscriber, to http://biotuesdays.com/ ProMIS Neurosciences (TSX:PMN) is the subject of ...

  • Avatar

    Ok....within a few hours ...I determined that it was not Promis Nuerosciences....I am interested in seeing which company...

  • Avatar

    ProMIS Neurosciences?...

  • Avatar

    While attending the conference in Toronto...you may want to pay particular attention to two different presentations by ...

  • We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

    More Info